3-O-(E)-p-coumaroyl tormentic acid from Eriobotrya japonica leaves induces caspase-dependent apoptotic cell death in human leukemia cell line

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 3, 2011, Pages 378-381

  Kikuchi, Takashi ^a   Akazawa, Hiroyuki ^a   Tabata, Keiichi ^a   Manosroi, Aranya ^b   Manosroi, Jiradej ^b   Suzuki, Takashi ^a   Akihisa, Toshihiro ^a  

^a NIHON UNIVERSITY   (Japan)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

3 O (E) p coumaroyl tormentic acid; Caspase dependent apoptosis; Cytotoxic activity; Eriobotrya japonica; Triterpene acid

Indexed keywords

3 EPIASIATIC ACID; 3 O 4 COUMAROYL TORMENTIC ACID; ANTILEUKEMIC AGENT; BETULIC ACID; CAMPTOTHECIN; CASPASE; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; COROSOLIC ACID; DELTA OLEANOLIC ACID; DNA TOPOISOMERASE; MASLINIC ACID; MEMBRANE PHOSPHOLIPID; METHYL BETULINATE; OLEANOLIC ACID; PROCASPASE 3; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL 2; TORMENTIC ACID; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; URSOLIC ACID; URSOLIC ACID METHYL ESTER;

APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CYTOTOXICITY; DNA FRAGMENTATION; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LOQUAT; MELANOMA CELL; MITOCHONDRION; PLANT LEAF; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL LINE, TUMOR; COUMARINS; DNA TOPOISOMERASES, TYPE I; ERIOBOTRYA; HUMANS; LEUKEMIA; PLANT LEAVES; PROTO-ONCOGENE PROTEINS C-BCL-2; TOPOISOMERASE I INHIBITORS; TRITERPENES;

EID: 79952412542     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.378     Document Type: Article

References (36)

1. Li W. L., Zheng H. C., Bukuru J., De Kimpe N., J. Ethnopharmacol., 92, 1-21 (2004).
2. Shimizu M., Fukumura H., Tsuji H., Tanaami S., Hayashi T., Morita N., Chem. Pharm. Bull., 34, 2614-2617 (1986).
3. De Tommasi N., De Simone F., Pizza C., Nahmood N., Moore P. S., Conti C., Orsi N., Stein M. L., J. Nat. Prod., 55, 1067-1073 (1992).
4. Young H.-S., Chung H.-Y., Lee C.-K., Park K.-Y., Yokozawa T., Oura H., Biol. Pharm. Bull., 17, 990-992 (1994).
5. Taniguchi S., Imayoshi Y., Kobayashi E., Takamatsu Y., Ito H., Hatano T., Sakagami H., Tokuda H., Nishino H., Sugita D., Shimura S., Yoshida T., Phytochemistry, 59, 315-323 (2002).
6. Huang Y., Li J., Cao Q., Yu S.-C., Lv X.-W., Jin Y., Zhang L., Zou Y.-H., Ge J.-F., Life Sci., 78, 2749-2757 (2006).
7. De Tommasi N., De Simone F., Cirino G., Cicala C., Pizza C., Planta Med., 57, 414-416 (1991).
8. Rollinger J. M., Kratschmar D. V., Schuster D., Pfisterer P. H., Gumy C., Aubry E. M., Brandstötter S., Stuppner H., Wolber G., Odermatt A., Bioorg. Med. Chem., 18, 1507-1515 (2010).
9. Akihisa T., Yasukawa K., "Biomaterials from Aquatic and Terrestrial Organisms," ed. by Fingerman M., Nagabhushanam R., Science Publ., Enfield, 2006, pp. 63-114.
10. Akihisa T., Oleoscience, 7, 445-453 (2007).
11. Banno N., Akihisa T., Tokuda H., Yasukawa K., Taguchi Y., Akazawa H., Ukiya M., Kimura, Y., Suzuki T., Nishino H., Biol. Pharm. Bull., 28, 1995-1999 (2005).
12. Song G.-Y., Kim Y., Zheng X.-G., You Y.-J., Cho H., Chung J.-H., Sok D.-E., Ahn B.-Z., Eur. J. Med. Chem., 35, 291-298 (2000).
13. Paquet C., Sane A.-T., Beauchemin M., Bertrand R., Leukemia, 19, 784-791 (2005).
14. Syrovets T., Büchele B., Gedig E., Slupsky J. R., Simmet T., Mol. Pharmacol., 58, 71-81 (2000).
15. Akihisa T., Kamo S., Uchiyama T., Akazawa H., Banno N., Taguchi Y., Yasukawa K., J. Nat. Med., 60, 331-333 (2006).
16. Tu H.-Y., Huang A-M., Wei B.-L., Gan K.-H., Hour T.-C., Yang S.-C., Pu Y.-S., Lin C.-N., Bioorg. Med. Chem., 17, 7265-7274 (2009).
17. Yan S.-L., Huang C.-Y., Wu S.-T., Yin M.-C., Toxicol. Vitro, 24, 842-848 (2010).
18. Xu Y., Ge R., Du J., Xin H., Yu T., Sheng J., Wang Y., Ling C., Cancer Lett., 284, 229-237 (2009).
19. Numata A., Yang P., Takahashi C., Fujiki R., Nabae M., Fujita E., Chem. Pharm. Bull., 37, 648-651 (1989).
20. Fernandes J., Castilho R. O., da Costa M. R., Wagner-Souza K., Kaplan M. A. C., Gattass C. R., Cancer Lett., 190, 165-169 (2003).
21. Liu W.-K., Ho J. C. K., Cheung F. W. K., Liu B. P. L., Ye W.-C., Che C.-T., Eur. J. Pharmacol., 498, 71-78 (2004).
22. Wada S., Tanaka R., Chem. Biodivers., 2, 689-694 (2005).
23. Kessler J. H., Mullauer F. B., de Roo G. M., Medema J. P., Cancer Lett., 251, 132-145 (2007).
24. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M. A., Lassota P., Traganos F., Cytometry, 13, 795-808 (1992).
25. Martin S. J., Reutelingsperger C. P., McGahon A. J., Rader J. A., van Schie R. C. A. A., LaFace D. M., Green D. R., J. Exp. Med., 182, 1545-1556 (1995).
26. Salvesen G. S., Dixit V. M., Cell, 91, 443-446 (1997).
27. Thornberry N. A., Lazebnik Y., Science, 281, 1312-1316 (1998).
28. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D., Science, 275, 1132-1137 (1997).
29. Kluck R. M., Esposti M. D., Perkins G., Renken C., Kuwana T., Bossy-Wetzel E., Goldberg M., Allen T., Barber M. J., Green D. R., Newmeyer D. D., J. Cell Biol., 147, 809-822 (1999).
30. Oltvai Z. N., Milliman C. L., Korameyer S. J., Cell, 74, 609-619 (1993).
31. Roos W. P., Kaina B., Trends Mol. Med., 12, 440-450 (2006).
32. Paquet C., Sane A.-T., Beauchemin M., Bertrand R., Leukemia, 19, 784-791 (2005).
33. Lassus P., Opitz-Araya X., Lazebnik Y., Science, 297, 1352-1354 (2002).
34. Reyes-Zurita F. J., Rufino-Palomares E. E., Lupiáñez J. A., Cascante M., Cancer Lett., 273, 44-54 (2009).
35. Kikuchi T., Nihei M., Nagai H., Fukushi H., Tabata K., Suzuki T., Akihisa T., Chem. Pharm. Bull., 58, 568-571 (2010).
36. Tabata K., Motani K., Takayanagi N., Nishimura R., Asami S., Kimura Y., Ukiya M., Hasegawa D., Akihisa T., Suzuki T., Biol. Pharm. Bull., 28, 1404-1407 (2005).